In vitro suppression of anti-DNA antibody and immunoglobulin synthesis in systemic lupus erythematosus patients by human gamma interferon
- PMID: 3132556
In vitro suppression of anti-DNA antibody and immunoglobulin synthesis in systemic lupus erythematosus patients by human gamma interferon
Abstract
The immunoregulator human gamma interferon (IFN-gamma) suppressed the spontaneous in vitro synthesis and secretion of anti-DNA antibodies by peripheral blood mononuclear cells of patients with systemic lupus erythematosus (SLE-PBMC). Comparable level of suppression were observed with both natural human IFN-gamma and recombinant derived human IFN-gamma. In addition, the inhibitory effects of human IFN-gamma were completely neutralized by a monoclonal antibody directed against it. Human IFN-gamma also inhibited the antigen induced production of anti-DNA synthesis by SLE-PBMC. Based on the kinetics of inhibition, human IFN-gamma appeared to be acting directly on the B cell. Lastly, human IFN-gamma also suppressed the spontaneous production of IgG and IgM by SLE-PBMC. Our findings support the conclusion that SLE Ig production can be regulated and that human IFN-gamma may be clinically useful in the treatment of SLE as well as other immune complex diseases.
Similar articles
-
IL-12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells (PBMC).Clin Exp Immunol. 1997 May;108(2):375-80. doi: 10.1046/j.1365-2249.1997.d01-1009.x. Clin Exp Immunol. 1997. PMID: 9158113 Free PMC article.
-
Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus.J Immunol. 1999 Dec 1;163(11):6306-13. J Immunol. 1999. PMID: 10570325
-
Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.Arthritis Rheum. 1999 Feb;42(2):328-37. doi: 10.1002/1529-0131(199902)42:2<328::AID-ANR16>3.0.CO;2-#. Arthritis Rheum. 1999. PMID: 10025928
-
Anti-DNA antibodies in systemic lupus erythematosus.Rheum Dis Clin North Am. 1992 May;18(2):437-54. Rheum Dis Clin North Am. 1992. PMID: 1626077 Review.
-
Targeting interferons in systemic lupus erythematosus: current and future prospects.Drugs. 2015 May;75(8):835-46. doi: 10.1007/s40265-015-0394-x. Drugs. 2015. PMID: 25940912 Review.
Cited by
-
Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation.J Inflamm Res. 2010;3:143-70. doi: 10.2147/JIR.S9425. Epub 2010 Dec 2. J Inflamm Res. 2010. PMID: 22096364 Free PMC article.
-
Cytokines and systemic lupus erythematosus.Ann Rheum Dis. 2000 Apr;59(4):243-51. doi: 10.1136/ard.59.4.243. Ann Rheum Dis. 2000. PMID: 10733469 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical